April 2, 2013
I have been working to assemble a data base of FDA/OPDP Warning and NOV letters spanning the years 2004-present, tracking activity through a number of fields. The database now includes hundreds of letters and covers nearly 1000 violations cited by … Continue reading →
March 4, 2013
To gain insight into the most recent thinking at FDA’s Office of Prescription Drug Promotion (OPDP), Eye on FDA regularly reviews the number of letters and types of violations that were cited by the agency each quarter in Warning Letters … Continue reading →
November 6, 2012
Happy Election Day. Make sure you vote! Are you considering putting together a video that contains a patient of physician testimonial? If you are, you will want to take extra care in considering two things – how you present your … Continue reading →
October 23, 2012
Each quarter Eye on FDA examines what has occurred in enforcement by the Office of Prescription Drug Promotion (OPDP), formerly known as the Division of Drug Marketing, Advertising, and Communications (DDMAC). Apart from being instructive for those working in communications … Continue reading →
October 9, 2012
Last week I reported on some of the activities during the Food and Drug Law Institute meeting on Advertising and Promotion which I attended here in Washington, where many aspects of enforcement were discussed. I had some data I did … Continue reading →